GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (NYSE:CRL) » Definitions » Cyclically Adjusted Price-to-FCF

Charles River Laboratories International (Charles River Laboratories International) Cyclically Adjusted Price-to-FCF : 30.91 (As of Apr. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Charles River Laboratories International Cyclically Adjusted Price-to-FCF?

As of today (2024-04-28), Charles River Laboratories International's current share price is $229.03. Charles River Laboratories International's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $7.41. Charles River Laboratories International's Cyclically Adjusted Price-to-FCF for today is 30.91.

The historical rank and industry rank for Charles River Laboratories International's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

CRL' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 19.63   Med: 30.12   Max: 77.15
Current: 30.89

During the past years, Charles River Laboratories International's highest Cyclically Adjusted Price-to-FCF was 77.15. The lowest was 19.63. And the median was 30.12.

CRL's Cyclically Adjusted Price-to-FCF is ranked better than
53.97% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 33.84 vs CRL: 30.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Charles River Laboratories International's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $2.779. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $7.41 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Charles River Laboratories International Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Charles River Laboratories International's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Cyclically Adjusted Price-to-FCF Chart

Charles River Laboratories International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.31 47.02 59.16 31.45 31.89

Charles River Laboratories International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.45 28.88 29.54 26.87 31.89

Competitive Comparison of Charles River Laboratories International's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Charles River Laboratories International's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Cyclically Adjusted Price-to-FCF falls into.



Charles River Laboratories International Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Charles River Laboratories International's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=229.03/7.41
=30.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Charles River Laboratories International's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.779/129.4194*129.4194
=2.779

Current CPI (Dec. 2023) = 129.4194.

Charles River Laboratories International Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.345 99.695 0.448
201406 0.999 100.560 1.286
201409 1.228 100.428 1.583
201412 1.521 99.070 1.987
201503 0.006 99.621 0.008
201506 1.511 100.684 1.942
201509 1.640 100.392 2.114
201512 1.927 99.792 2.499
201603 0.779 100.470 1.003
201606 1.420 101.688 1.807
201609 1.292 101.861 1.642
201612 1.954 101.863 2.483
201703 0.364 102.862 0.458
201706 1.754 103.349 2.196
201709 0.774 104.136 0.962
201712 1.956 104.011 2.434
201803 0.662 105.290 0.814
201806 2.093 106.317 2.548
201809 1.922 106.507 2.335
201812 1.463 105.998 1.786
201903 -0.038 107.251 -0.046
201906 2.110 108.070 2.527
201909 2.428 108.329 2.901
201912 2.342 108.420 2.796
202003 0.858 108.902 1.020
202006 2.697 108.767 3.209
202009 2.980 109.815 3.512
202012 0.984 109.897 1.159
202103 2.784 111.754 3.224
202106 2.730 114.631 3.082
202109 2.312 115.734 2.585
202112 2.528 117.630 2.781
202203 0.432 121.301 0.461
202206 1.299 125.017 1.345
202209 1.178 125.227 1.217
202212 2.838 125.222 2.933
202303 0.049 127.348 0.050
202306 1.569 128.729 1.577
202309 2.703 129.860 2.694
202312 2.779 129.419 2.779

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Charles River Laboratories International  (NYSE:CRL) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Charles River Laboratories International Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International (Charles River Laboratories International) Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Executives
Victoria L Creamer officer: EVP & Chief People Officer 164 PINE HILL ROAD, NEW FAIRFIELD CT 06812
Joseph W Laplume officer: EVP, Corp Strategy & Develop 251 BALLARDVALE STREET, WILMINGTON MA 01887
Birgit Girshick officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
James C Foster director, officer: President and CEO 251 BALLARDVALE ST, WILMINGTON MA 01887
Richard F Wallman director HONEYWELL, 101 COLUMBIA ROAD, MORRISTOWN NJ 07962
William D Barbo officer: Corporate Executive VP & CCO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Michael Gunnar Knell officer: CSVP&Chief Accounting Officer BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
George Massaro director
Shannon M Parisotto officer: CEVP, Disc & Safety Assessment 251 BALLARDVALE ST, WILMINGTON MA 01887
Flavia Pease officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
David Ross Smith officer: Corporate Executive VP & CFO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Deborah Turner Kochevar director 251 BALLARDVALE STREET, WILMINGTON MA 01887
Milne George M Jr director
Stephen D Chubb director C/O MATRITECH INC, 330 NEVADA STREET, NEWTON MA 02460
George Llado director 251 BALLARDVALE STREET, WILMINGTON MA 01887